ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

DCPC Board To hear To Hear Concept for Contract to Develop Program For Heavy Smokers

January 11, 1985

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

NCI Proposes Three New Grant Programs In Nutrition And Research; DRCCA Board, NCAB Approval Required

November 28, 1980

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979